Table 1.
Demographic and Clinical Characteristics
| Characteristic | Number of Patients (%) |
|---|---|
|
| |
| N | 121 |
|
| |
| Median Age and range | 52 (19 – 88) |
|
| |
| Gender | |
| Male | 80 (66) |
| Female | 41 (34) |
|
| |
| Year of diagnosis | |
| Before 2007 | 64 (53) |
| During and after 2007 | 57 (47) |
|
| |
| B symptoms | |
|
| |
| Yes | 40 (33) |
|
| |
| No | 78(64) |
|
| |
| Missing | 3 (2) |
|
| |
| Stage | |
| I/II | 83 (69) |
| III/IV | 38 (31) |
|
| |
| Race | |
| White | 71 (59) |
| Asian | 25 (21) |
| Black | 3 (2) |
| Hispanic/American India | 20 (17) |
| Unknown | 2 (2) |
|
| |
| EBV status (tissue biopsy) | |
| Positive by Fish or IHC1 | 89 (74) |
| Negative2 | 17 (14) |
| Unknown | 15 (12) |
EBV, Epstein-Barr virus; FISH, fluorescent in-situ hybridization; IHC, immunohistochemistry.
1
Positive EBV status was determined by FISH in 69 patients, IHC in 19 patients, and an unknown testing modality in 1 patient.
2
Negative EBV status was determined by FISH in 8 patients, IHC in 1 patient, and an unknown testing modality in 8 patients.